Stock market news

Artgen

Human Stem Cells Institute's RAS net income for 3 months of 2023 was ₽8.28 million, down 9 times from ₽75.17 million in the previous year. Revenue fell 48.2% to ₽15.38 million versus ₽29.68 million a year earlier.

IMCB

IMCB's RAS net income for 3 months of 2023 remained the same as last year at ₽34 million Revenue increased 5.6% to ₽69.233 million versus ₽65.584 million a year earlier.

Artgen

Human Stem Cell Institute's IFRS net income for 2022 was ₽23.075 million, down 31.2% from ₽33.547 million in the previous year. Revenue fell 3.7% to ₽1.137 billion compared to ₽1.181 billion a year earlier.

LUKOIL

Average daily hydrocarbon production by Lukoil Group, excluding the West Qurna-2 project, was 2.315 million boe in 2022, an increase of 7% compared to 2.163 million boe in the previous year. Oil production with gas condensate increased by 7.1% to 85 million tons. Gas production increased by 7.6% to 34.6 billion cubic meters.

Seligdar

Seligdar expects to develop a gold extraction technology for the Kyuchus deposit following studies in 2023-2024. Choosing the technology for enrichment and extraction of gold from the Kyuchus refractory ores is an important issue of development. Percentage of uncyanized gold in the primary ore reaches 99%. Extraction of 87% in the enriched product is obtaine...

Territorial Generating Company № 2

TGC-2's IFRS net income for 2022 was ₽1.462 billion, against a loss of ₽0.932 billion in the previous year. Revenue increased by 0.9% to ₽47.438 billion against ₽47.009 billion a year earlier.

Samaraenergo

Samaraenergo's IFRS net income for 2022 was ₽1.122 billion, up 37.7% from ₽0.815 billion in the previous year. Revenue increased 2.4% to ₽40.755 billion, compared to ₽39.803 billion a year earlier.

Oak Street Health

CVS Health closed the deal to buy Oak Street Health for $10.6 billion, or $39 a share.

Sollers

Sollers' RAS loss for 3 months of 2023 was ₽207.31 million, against a profit of ₽67.55 million in the previous year.

Bashinformsvyaz

Bashinformsvyaz's RAS net profit for 3 months of 2023 was ₽149.05 million, against a loss of ₽147.16 million in the previous year. Revenue decreased by 3.7% to ₽1.279 billion versus ₽1.328 billion a year earlier.